Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evolving revascularization approaches for myocardial ischemia.

Neal S Kleiman1, Nirav C Patel, Keith B Allen

  • 1Baylor College of Medicine and The Methodist DeBakey Heart Center, Houston, Texas, USA. nkleiman@bcm.tmc.edu

The American Journal of Cardiology
|November 15, 2003
PubMed
Summary

Stable angina treatment involves medical therapy and revascularization procedures like angioplasty and bypass surgery. Newer approaches, including therapeutic angiogenesis, aim to stimulate new blood vessel growth for improved coronary blood supply.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Remote Patient Monitoring with Care Utilization in Patients with Chronic Cardiopulmonary Conditions.

Studies in health technology and informatics·2026
Same author

Redo-TAVR (TAV-in-TAV) Best Practices Part 1: Short-in-Short and Short-in-Tall - A Heart and Valve Collaboratory Document.

JACC. Cardiovascular interventions·2026
Same author

Redo-TAVR (TAV-in-TAV) Best Practices Part 2: Tall-in-Short and Tall-in-Tall - A Heart and Valve Collaboratory Document.

JACC. Cardiovascular interventions·2026
Same author

Commentary: Transcatheter electrosurgery: Telsa's AC or Edison's DC? Only Time Will Tell.

JTCVS structural and endovascular·2026
Same author

Metabolic control of smooth muscle cell phenotype switching in atherosclerosis.

bioRxiv : the preprint server for biology·2026
Same author

Bioprosthetic valve fracture during valve-in-valve transcatheter aortic valve replacement: patient selection, procedural timing, and technical optimization.

Expert review of medical devices·2026

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Stable angina pectoris, a symptom of ischemic heart disease, significantly impacts patient quality of life.
  • Current medical therapies aim to manage symptoms and reduce cardiac events by balancing myocardial oxygen supply and demand.

Purpose of the Study:

  • To review established and emerging revascularization strategies for chronic stable angina.
  • To highlight advancements in percutaneous coronary intervention and coronary artery bypass grafting.
  • To explore novel approaches like therapeutic angiogenesis for coronary revascularization.

Main Methods:

  • Review of percutaneous transluminal coronary angioplasty (PTCA) with stent advancements (bare metal and drug-eluting).
  • Overview of coronary artery bypass graft (CABG) surgery refinements focusing on reduced invasiveness and complications.

Related Experiment Videos

  • Discussion of newer techniques including laser transmyocardial revascularization and therapeutic angiogenesis.

    • Main Results:

    • PTCA and CABG remain primary invasive revascularization methods.
    • Drug-eluting stents have improved outcomes by reducing restenosis.
    • CABG innovations focus on minimally invasive techniques and improved anastomotic devices.
    • Therapeutic angiogenesis shows promise for stimulating collateral vessel growth in ischemic myocardium.

    Conclusions:

    • Medical therapy is the first line for stable angina, with invasive revascularization considered when inadequate.
    • Advancements in PTCA and CABG continue to refine treatment efficacy and safety.
    • Therapeutic angiogenesis and gene therapy represent promising future directions for managing chronic ischemic heart disease.